Safety of Lumason® (SonoVue®) in special populations and critically ill patients
Evidence for the safe use of Lumason® (SonoVue®), an ultrasound enhancing agent (UEA), in special patient populations is critical to enable healthcare professionals to make informed decisions concerning its use in such patients. Herein, we provide insight on the safety and tolerability of Lumason® i...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2023-08-01
|
| Schriftenreihe: | Frontiers in Cardiovascular Medicine |
| Schlagworte: | |
| Online-Zugang: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1225654/full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|